ABL1 and acute lymphoblastic leukemia: In B-ALL, detecting the Philadelphia chromosome resulting from the BCR-ABL1 fusion gene has important implications for determining eligibility for targeted therapies with tyrosine kinase inhibitors (TKIs) Inizio moduloand and for monitoring MRD to implement treatment choices [37].